Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma therapy successfully healed a chronic wound from tophi rupture.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

Papillon-Lefèvre Syndrome causes early tooth loss and skin issues, needing early dental diagnosis.

Apremilast improved symptoms in patients with severe skin conditions.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Dupilumab effectively treats severe skin issues in a rare genetic disorder.

A new gene mutation may cause cyclic thrombocytopenia by affecting platelet production.

PCE-DP brightens skin and promotes hair growth by enhancing cell growth and reducing melanin uptake.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

The S100A4 protein is more common in psoriatic skin and could be a target for treating psoriasis.

New mutations in the EBP gene cause CDPX2, affecting bones, skin, eyes, and hair, with females generally less affected than males.

CMG2 and TEM8 receptors have distinct roles in skin and growth disorders, affecting collagen breakdown and growth.

The care model improved timely diagnosis and treatment for psoriasis and psoriatic arthritis.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Dupilumab effectively improves skin conditions, reduces symptoms, and enhances quality of life in certain dermatological issues.

Dupilumab improves skin microbiome balance in atopic dermatitis patients.

Silver nanoparticles made from Tridax procumbens leaves can kill bacteria and help treat infections.

HPDAlR nanoparticles greatly improve skin wound healing without toxicity.

PLGA-based microneedles are promising for safe and effective skin delivery of drugs and vaccines.

Cathelicidins could treat skin issues but face challenges like safety and resistance.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

PTHrP is higher in certain dog tumors and may act as a local growth factor.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

"Akaro Spectra" tablets effectively eliminate dog parasites within two days.

Vaccines work well in Netherton syndrome patients, similar to healthy people.

Pegvaliase is recommended for treating adults with phenylketonuria.